Debevoise Advises Blackstone in Its Investment in Ginger

24 March 2021

Debevoise & Plimpton LLP is advising The Blackstone Group in its investment in Ginger as part of a $100 million Series E funding round. For more information, please see the company’s press release.

With this latest round of funding, Ginger will seek to continue expanding access to value-based mental healthcare through additional partnerships with multinational employers and health plans. In the first half of the year, the company also plans to extend its reach to support underserved populations through new government payer relationships and collaborations with non-profit organizations. In addition, this funding will enable Ginger to continue its acquisition of innovative technologies and clinical services to improve and scale its on-demand mental health system.

Ginger is a leader in on-demand mental healthcare and through its app provides members with access to unlimited self-guided care and 24/7 on-demand coaching, as well as video-based therapy and psychiatry support.

The Debevoise team is led by M&A partner Kevin Rinker and includes counsel David Iozzi and associates Eli Bienstock, Kim Le, Hannah Levine and James Malmo, benefits partner Meir Katz associate Matthew Trudeau, tax partner Peter Furci intellectual property associate Tigist Kassahun and FDA regulatory partner Paul Rubin.